Dyne Therapeutics (DYN) Interest Coverage Ratio (2019 - 2026)

Dyne Therapeutics' (DYN) quarterly Interest Coverage Ratio came in at 2.54 in Q1 2026, up 86.42% year-on-year from 1.36 in Q1 2025, and up 94.44% on a QoQ basis from 45.61 in Q4 2025.

Dyne Therapeutics (DYN) Interest Coverage Ratio (2019 - 2026) Analysis & Trends

Dyne Therapeutics (DYN) has 8 years of Interest Coverage Ratio data on file, last reported at 2.54 in Q1 2026.

  • On a quarterly basis, Interest Coverage Ratio rose 86.42% year-over-year to 2.54 in Q1 2026; TTM through Mar 2026 was 9.54, a 84.26% increase from a year earlier, with the FY2025 full-year figure at 8.87, down 644.58% from the prior year.
  • Interest Coverage Ratio for Q1 2026 stood at 2.54, up from 45.61 in the prior quarter.
  • Over the last five years, Interest Coverage Ratio for DYN reached as high as 0.35 in Q4 2022 and fell as low as 1231.82 in Q2 2025.
  • Historically, Interest Coverage Ratio has averaged 85.83 across 5 years, with a median of 2.53 in 2026.
  • Across the five-year window, Interest Coverage Ratio jumped 99.86% in 2022 and plunged 304624.69% in 2025, its largest moves.
  • Year by year, Interest Coverage Ratio stood at 0.35 in 2022, then tumbled by 31.42% to 0.46 in 2023, then slumped by 4098.65% to 19.5 in 2024, then plunged by 133.96% to 45.61 in 2025, then soared by 94.44% to 2.54 in 2026.
  • Per Business Quant data, the three most recent Interest Coverage Ratio figures were 2.54 in Q1 2026, 45.61 in Q4 2025, and 39.22 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 658.42
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 7.60
4 NuCana 279.75 Bn 279.75 Bn - -0.22
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 2.71
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.72
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -0.38
10 Dyne Therapeutics 3.94 Bn 3.94 Bn - -2.54

Historic Data

Download Data
DateValue
Mar 31, 2026 -2.54
Dec 31, 2025 -45.61
Sep 30, 2025 -39.22
Jun 30, 2025 -1,231.82
Mar 31, 2025 -18.68
Dec 31, 2024 -19.50
Jun 30, 2024 -0.40
Mar 31, 2024 -0.52
Dec 31, 2023 -0.46
Sep 30, 2023 -4.02
Jun 30, 2023 -2.52
Mar 31, 2023 -1.41
Dec 31, 2022 -0.35
Sep 30, 2022 -0.99
Jun 30, 2022 -3.91
Mar 31, 2022 -1.37
Dec 31, 2021 -255.96
Sep 30, 2021 -0.70
Jun 30, 2021 -0.32
Mar 31, 2021 -0.42